Skip to content

Reliability and Validity of Pittsburgh Rehabilitation Participation Scale During Robot Therapy

Reliability and Validity of Pittsburgh Rehabilitation Participation Scale During Robot Therapy Among Patients with Stroke

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06756958
Enrollment
46
Registered
2025-01-03
Start date
2017-09-01
Completion date
2021-10-31
Last updated
2025-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

participation, robot, scale, rehabilitation

Brief summary

Reliability and validity of Pittsburgh Rehabilitation Participation Scale during robot therapy among patients with stroke

Interventions

OTHERNo intervention (observational study)

No intervention (observational study: The study participants were inpatient and were given robot-assisted gait training routinely.)

Sponsors

National Rehabilitation Center, Seoul, Korea
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with stroke or traumatic brain injury * inpatient in rehabilitation center

Exclusion criteria

* brain tumor * spinal cord injury

Design outcomes

Primary

MeasureTime frameDescription
Pittsburgh Rehabilitation Participation Scalethrough study completion, an average of 3 yearPittsburgh Rehabilitation Participation Scale could be 1 (none), 2, 3, 4, 5, or 6 (excellent). Excellent (6): If the patient participated in all exercises or activities with maximal effort, finished all exercises or activities, and actively took interest in exercises or activities and/or future therapy sessions. None (1): patient refused entire session, or did not participate in any exercises or activities in session. In this study, a participant typically gets 12 sessions of robot assisted gait training. Just after the each session, Pittsburgh Rehabilitation Participation Scale is assigned as 1 to 6. For example, in a virtual case, the participant gets the score of 1, 1, 2, 2, 3, 3, 4, 4, 5, 5, 6, and 6 (median =3.5). the participant gets 12 numbers of outcome score and median of Pittsburgh Rehabilitation Participation Scale.

Secondary

MeasureTime frameDescription
10m walkbaseline and 4 weeks from baseline
Borg scalebaseline and 4 weeks from baselineBorg scale measures perceived exertion during the test. It ranges 13 to 20. 13 means easy. 20 means hardest.
6 min walkbaseline and 4 weeks from baseline
motricity indexbaseline and 4 weeks from baseline
Berg balance scalebaseline and 4 weeks from baselineBerg balance scale is the combination of 16 5-point-Likert-scale-like ordinal scale of 0 to 4. O means no balance. 56 means the maximal balance as the criteria.
Trunk impairment scalebaseline and 4 weeks from baselineScores range from a minimum of 0 to a maximum of 23. Zero means no balance. 23 means maximal balance and trunk function.
modified Barthel Indexbaseline and 4 weeks from baselineModified Barthel Index measures basic activities of daily life. Lowest score is zero and means no function. Highiest score is 100, best function.
Modified Rankin Scale for Neurologic Disabilitybaseline and 4 weeks from baselineModified Rankin Scale for Neurologic Disability could be 0, 1, 2, 3, 4, 5, or 6. Zero (0) means no negative symptoms et al as the criteria. 6 means means dead condition (death) as the criteria.
Functional Ambulatory Categorybaseline and 4 weeks from baseline
Timed Timed Up and Go testbaseline and 4 weeks from baseline
Manual Muscle Testingbaseline and 4 weeks from baseline
modified Ashworth scalebaseline and 4 weeks from baselineModified Ashworth scale could be 0, 1, 1+, 2, 3, or 4. Zero (0) means no spasticity as the criteria. 4 means means maximal spasticity as the criteria.
National Institutes of Health Stroke Scalebaseline and 4 weeks from baseline0 to 24 points. Zero (0) means no deficits as the criteria. 24 means means maximal deficits as the criteria.
Function in sitting testbaseline and 4 weeks from baseline

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026